Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Ahmed Al‑Darraji, Renée R. Donahue, Himi Tripathi, Hsuan Peng, Bryana M. Levitan, Lakshman Chelvarajan, Dalia Haydar, Erhe Gao, David Henson, John C. Gensel, David J. Feola, Vincent J. Venditto, Ahmed Abdel‑Latif |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bae5946a3c14d12a1ef4f74cf974221 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adult spiny mice (Acomys) exhibit endogenous cardiac recovery in response to myocardial infarction
por: Hsuan Peng, et al.
Publicado: (2021) -
Immunotherapeutic Advances for NSCLC
por: Massafra M, et al.
Publicado: (2021) -
Novel Immunotherapeutic Approach in Gastric Cancer
por: Gulubova M., et al.
Publicado: (2020) -
Topical azithromycin or ofloxacin for endophthalmitis
por: Stewart ML, et al.
Publicado: (2012) -
Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolution.
por: Niyaz Ahmed, et al.
Publicado: (2007)